SB-REG – Sanford Biotech's line of veterinary cell medicines
Sanford Biotech is developing a series of modern vATMP (veterinary Advanced Therapy Medicinal Products) biological medicines based on mesenchymal stem cells (MSCs). Each candidate has been designed with specific species and disease needs in mind – from osteoarthritis and neurological diseases to mastitis in dairy cattle.
All SB-REG products are manufactured under GMP conditions, in accordance with EMA and VICH GL9 guidelines, and their efficacy is confirmed by translational studies conducted in collaboration with leading research centres in Poland and the USA.